International Menopause Society (IMS) 21st World Congress on Menopause

The International Menopause Society (IMS) 21st World Congress on Menopause focuses on menopause-related medicine, addressing clinical research, diagnosis, treatment approaches, and the wide-ranging biological, metabolic, and psychosocial impacts of menopause.

Key Topics

• Menopause diagnosis and epidemiology
  • Diagnosis of menopause
  • Epidemiology, basic science and clinical research
  • Biochemical prediction of age at menopause
• Hormonal and non-hormonal therapies
  • Hormone and non-hormonal therapy
  • Selective hormone receptor modulators
  • Novel treatments and regimens
• Vulvovaginal and urogenital health
  • Genitourinary syndrome of menopause
  • Vulvovaginal atrophy treatment options
  • Lower urinary tract symptoms and pelvic organ prolapse
• Cardiovascular and metabolic health
  • Metabolic syndrome and obesity
  • Hormones and coronary heart disease
  • Insulin resistance, diabetes and dyslipidemia
• Neurological and cognitive health
  • Cognitive function and neurodegenerative disorders
  • Sleep disorders and neurosteroids
  • Menopause and the brain
• Bone and musculoskeletal health
  • Osteoporosis and bone loss
  • Sarcopenia
  • Fracture prevention strategies
• Breast and oncology topics
  • Breast cancer epidemiology and prevention
  • Hormone therapy and breast cancer
  • Non-gynecological cancer in menopause
• Gynecology and reproductive health
  • Fibroids and endometriosis
  • Abnormal uterine bleeding
  • PCOS and endometrial cancer
• Mood, sexual function, and mental health
  • Mood disorders and perimenopausal depression
  • Sexual function treatment options
  • Schizophrenia and mental disorders

Who should attend

• Clinicians in menopause care
• Researchers in women’s health
• Gynecologists
• Endocrinologists
• Basic science researchers
• Clinical researchers
• Healthcare professionals interested in hormonal medicine